Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.
Professor Roy Taylor has announced the results of his ReTUNE study, funded by Diabetes UK, showing for the first time that remission of type 2 diabetes is possible for people..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced the results of the proposal from a number of..
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has provided an update on the strengthening of its intellectual..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, noted the announcement..
Cambridge Cognition Holdings plc (LON:COG), a technology company which develops and markets patient-focused solutions to better assess brain health, has announced its unaudited preliminary results for the year ended 31st..
Cizzle Biotechnology plc (LON:CIZ), the UK based diagnostics developer, has announced that it has entered into a further research agreement with the University of York for the development of potential..
Goodbody Health Inc. (AQSE:GDBY) has announced that its subsidiary, PhytoVista Laboratories, has been granted a controlled drugs licence that allows the company to handle up to Schedule 1 Controlled Drugs...
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced the signing of two new ImmunoINSIGHTS commercial contracts. The first contract is with an US-based clinical-stage biopharmaceutical company which..
Cambridge Cognition Holdings plc (LON: COG), which develops and markets digital solutions to assess brain health, has announced two senior management appointments. Stephen Symonds has joined the Company as its..
The Cannabidiol (CBD) market has become big business thanks to the compound’s perceived health and wellness benefits. The UK CBD market is estimated to be worth £690 million ($929 million/€824..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF) has announced that it has signed a Clinical Trial Agreement with the Centre for Human Drug Research (CHDR) in the Netherlands for the completion of..
The Lancet, one of the leading Medical Science researchers, published in their Diabetes & Endocrinology journal on 21 March 2022 a new paper examining the post-acute risk and burden of..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a contract worth just over £1 million with a..
A study conducted by Boston University scientists on over 5,000 adults throughout their lives, suggests that having high cholesterol levels in your thirties could raise your risk of Alzheimer’s later..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO,..
Poolbeg Pharma plc (LON:POLB) today announced that it has signed a deal with CytoReason, a leading artificial intelligence (AI) company developing computational disease models for efficient drug discovery and development,..
Poolbeg Pharma plc (LON:POLB), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, announced today that it has signed a deal with CytoReason, a leading..
Cambridge Cognition Holdings plc (LON: COG), which develops and markets digital solutions to assess brain health, is pleased to announce the appointment of Panmure Gordon (UK) Limited as the Company’s..
NHS England chiefs are concerned that the public is being put off seeking help when they have cancer symptoms because they do not want to be a burden to the..
The stark impact of the COVID pandemic in disrupting health and care services is laid bare in a recent survey of more than 1,000 UK patients carried out by the..
